All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of secondary growth | GO_2000604 | [Any process that stops, prevents or reduces the frequency, rate or extent of secondary growth.] |
| 3-(2,3-dihydroxyphenyl)propanoate catabolic process | GO_1901791 | [The chemical reactions and pathways resulting in the breakdown of 3-(2,3-dihydroxyphenyl)propanoate.] |
| 3-(2,3-dihydroxyphenyl)propanoate biosynthetic process | GO_1901792 | [The chemical reactions and pathways resulting in the formation of 3-(2,3-dihydroxyphenyl)propanoate.] |
| 3-(3-hydroxyphenyl)propanoate metabolic process | GO_1901793 | [The chemical reactions and pathways involving 3-(3-hydroxyphenyl)propanoate.] |
| 3-(3-hydroxyphenyl)propanoate catabolic process | GO_1901794 | [The chemical reactions and pathways resulting in the breakdown of 3-(3-hydroxyphenyl)propanoate.] |
| 3-(3-hydroxyphenyl)propanoate biosynthetic process | GO_1901795 | [The chemical reactions and pathways resulting in the formation of 3-(3-hydroxyphenyl)propanoate.] |
| signal transduction by p53 class mediator | GO_0072331 | [An intracellular signaling process that is induced by the cell cycle regulator phosphoprotein p53 or an equivalent protein.] |
| oxytocin receptor activity | GO_0004990 | [Combining with oxytocin to initiate a change in cell activity.] |
| parathyroid hormone receptor activity | GO_0004991 | [Combining with parathyroid hormone to initiate a change in cell activity.] |
| platelet activating factor receptor activity | GO_0004992 | [Combining with platelet activating factor to initiate a change in cell activity.] |
| negative regulation of proteasomal protein catabolic process | GO_1901799 | [Any process that stops, prevents or reduces the frequency, rate or extent of proteasomal protein catabolic process.] |
| G protein-coupled serotonin receptor activity | GO_0004993 | [Combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates.] |
| serotonin receptor activity | GO_0099589 | [Combining with the biogenic amine serotonin and transmitting a signal across a membrane by activating some effector activity. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates.] |
| serotonin binding | GO_0051378 | [Interacting selectively and non-covalently with serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.] |
| G protein-coupled serotonin receptor signaling pathway | GO_0098664 | [The series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands.] |
| somatostatin receptor activity | GO_0004994 | [Combining with somatostatin to initiate a change in cell activity. Somatostatin is a peptide hormone that regulates the endocrine system by signaling via G protein-coupled somatostatin receptors. Somatostatin has two active forms produced by proteolytic cleavage: a 14 amino acid peptide (SST-14) and a 28 amino acid peptide (SST-28).] |
| somatostatin signaling pathway | GO_0038170 | [The series of molecular signals generated as a consequence of the peptide somatostatin (SST) binding to a somatostatin receptor (SSTR). The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.] |
| tachykinin receptor activity | GO_0004995 | [Combining with a tachykinin neuropeptide and transmitting the signal across the membrane by activating an associated G-protein.] |
| tachykinin receptor signaling pathway | GO_0007217 | [The series of molecular signals generated as a consequence of a tachykinin, i.e. a short peptide with the terminal sequence (Phe-X-Gly-Leu-Met-NH2), binding to a cell surface receptor.] |
| thyroid-stimulating hormone receptor activity | GO_0004996 | [Combining with thyroid-stimulating hormone to initiate a change in cell activity.] |